2026 data FDA MAUDE openFDA

Radioimmunoassay, Vancomycin

Adverse-event figures are drawn from the U.S. Food & Drug Administration (FDA) MAUDE database, refreshed March 2026, see our methodology.

OpenFDA device adverse-event casebook.

FDA MAUDE casebook

openFDA event book Radioimmunoassay, Vancomycin LIGHT-BOOK · MAUDE

#876 of 1000 · 494 reports · 2002–2026

  • BOOK 494 reports
  • RANK #876 of 1000
  • DEATH 1 death-typed
  • INJ 4 injury-typed
  • MALF 477 malfunction
  • SPAN 2002–2026
  • PEAK 2012: 80
  • PHOTO Prosthesis

Nearest event-volume peer: Prosthesis, Wrist, 3 Part Metal-Plastic-Metal Articulation, Semi-Constrained (0 report gap)

Radioimmunoassay, Vancomycin sits #876 of 1000 among tracked device types with 494 MAUDE reports spanning 2002–2026. Rank counts report volume, not confirmed device fault. Event_type Death / Injury / Malfunction are one code per report — not the same population as patient-outcome rows ( methodology). Read with this device → · Lead manufacturer → · Similar-volume device →

Event-type mix vs corpus

Shares of FDA event_type codes on this device type, compared with the mean across 1,000 device types that have ≥100 MAUDE reports. Codes are report labels, not adjudicated causation.

  • DEATH 0.2% corpus 1.5% · below corpus mean (-1.3 pp)
  • INJ 0.8% corpus 30.4% · below corpus mean (-29.6 pp)
  • MALF 96.6% corpus 64.5% · above corpus mean (+32.1 pp)

Lead product-problem code Low Test Results is 49% of coded problems · Lead manufacturer ROCHE DIAGNOSTICS accounts for 36% of manufacturer-tagged reports · Top event location is 69% of location-tagged rows .

Radioimmunoassay, Vancomycin in the event-volume neighbourhood

FDA MAUDE report totals among this device type and nearest nationwide peers

reports

What this shows Radioimmunoassay, Vancomycin carries 494 MAUDE reports, ranked #876 of 1000.

Source FDA MAUDE via openFDA, aggregated by PlainHospital As of August 2026

Event Types

Malfunction 477 (96.6%)
Other 10 (2.0%)
Injury 4 (0.8%)
2 (0.4%)
Death 1 (0.2%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

478 (96.6%)
Other 14 (2.8%)
S 1 (0.2%)
Congenital Anomaly 1 (0.2%)
Required Intervention 1 (0.2%)

Top Product Problems

Low Test Results 73
High Test Results 38
Incorrect, Inadequate or Imprecise Result or Readings 7
Non Reproducible Results 6
Adverse Event Without Identified Device or Use Problem 5
Incorrect Measurement 5
Low Readings 4
Device Ingredient or Reagent Problem 3
Cross Reactivity 2
Erratic Results 1
False Negative Result 1
High Readings 1
Incorrect Or Inadequate Test Results 1
Insufficient Information 1
Unexpected Therapeutic Results 1

Yearly Trend

02
2002: 1
07
2007: 4
08
2008: 12
09
2009: 25
10
2010: 48
11
2011: 55
12
2012: 80
13
2013: 73
14
2014: 40
15
2015: 26
16
2016: 10
17
2017: 15
18
2018: 17
19
2019: 13
20
2020: 14
21
2021: 11
22
2022: 7
23
2023: 11
24
2024: 14
25
2025: 14
26
2026: 4

Related Entities for Radioimmunoassay, Vancomycin

Event Locations

343 (69.4%)
I 79 (16.0%)
LABORATORY 63 (12.8%)
OTHER 8 (1.6%)
HOSPITAL 1 (0.2%)

Compare ROCHE DIAGNOSTICS vs ORTHO-CLINICAL DIAGNOSTICS →

Nationwide devices with similar MAUDE profiles

Two openFDA-derived peer sets for Radioimmunoassay, Vancomycin, both floored at ≥100 reports so the neighborhoods stay in the advertised mass.

Similar report volume

Nearest other device types by FDA MAUDE report count (494 here).

Similar death-typed counts

Nearest other device types by death-typed report count (1 here), distinct from the volume row.

Disclaimer: MAUDE figures for Radioimmunoassay, Vancomycin are informational only and are not clinical advice. Report codes do not prove device causation. Consult a qualified clinician before acting on this data.

Every figure on PlainHospital is rendered directly from federal source data, no number is typed in by an editor. Event-type mix on this page is computed from FDA MAUDE codes for Radioimmunoassay, Vancomycin; corpus means use device types with ≥100 reports. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.